Inventor · disambiguated record
Bruce W. Lyday
Also filed as: LYDAY BRUCE · LYDAY BRUCE W · LYDAY BRUCE WILLIAM
12 granted patents·6 pending applications·69 citations·filing 1998–2022
90Inventor score
Top patents by PatentIndex Score
18 records- 0191US10946080B2Compositions and methods for combination therapy with dengue virus and dendritic cellsPRIMEVAX IMMUNO ONCOLOGY INC·Filed 2019·Granted Mar 16, 2021·3 cites·20 claims
- 0291US10675304B2Combination immunotherapies for treatment of cancerPRIMEVAX IMMUNO ONCOLOGY INC·Filed 2019·Granted Jun 9, 2020·4 cites·14 claims
- 0391US9849167B2Compositions and methods for combination therapy with dengue virus and dendritic cellsPRIMEVAX IMMUNO-ONCOLOGY INC·Filed 2017·Granted Dec 26, 2017·8 cites·9 claims
- 0490US11357795B2Combination immunotherapies for treatment of cancerPRIMEVAX IMMUNO ONCOLOGY INC·Filed 2020·Granted Jun 14, 2022·2 cites·9 claims
- 0590US9730989B2Compositions and methods for combination therapy with dengue virus and dendritic cellsPRIMEVAX IMMUNO-ONCOLOGY INC·Filed 2016·Granted Aug 15, 2017·7 cites·20 claims
- 0687US10357553B2Compositions and methods for combination therapy with dengue virus and dendritic cellsPRIMEVAX IMMUNO ONCOLOGY INC·Filed 2018·Granted Jul 23, 2019·4 cites·23 claims
- 0787US10159727B2Compositions and methods for combination therapy with dengue virus and dendritic cellsPRIMEVAX IMMUNO ONCOLOGY INC·Filed 2017·Granted Dec 25, 2018·4 cites·14 claims
- 0887US6524587B1Hyperthermia and immunotherapy for leukemias lymphomas, and solid tumorsFiled 2000·Granted Feb 25, 2003·21 cites·30 claims
- 0979US12377115B2Combination immunotherapies for treatment of cancerPRIMEVAX IMMUNO ONCOLOGY INC·Filed 2022·Granted Aug 5, 2025·0 cites·9 claims
- 1078US10765727B2Compositions and methods for producing dendritic cellsPRIMEVAX IMMUNO ONCOLOGY INC·Filed 2016·Granted Sep 8, 2020·1 cites·11 claims
- 1173US2021187086A1Compositions and methods for combination therapy with dengue virus and dendritic cellsPRIMEVAX IMMUNO ONCOLOGY INC·Filed 2021·Application pending·0 cites
- 1269US12059443B2Method for treating cancer using dengue virus serotype 1 (DENV-1)PRIMEVAX IMMUNO ONCOLOGY INC·Filed 2020·Granted Aug 13, 2024·0 cites·12 claims
- 1359US2020078424A1Compositions and methods for therapy with dengue virusPRIMEVAX IMMUNO ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 1459US2022193225A1Compositions and methods for sars-2 vaccine with virus replicative particles and recombinant glycoproteinsLYDAY BRUCE·Filed 2021·Application pending·0 cites
- 1559US2020360497A1Compositions and methods for producing dendritic cellsPRIMEVAX IMMUNO ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 1657US6048686AHyperthermia and immunotherapy for cancerRANDY KYLE BROWN·Filed 1998·Granted Apr 11, 2000·15 cites·6 claims
- 1751US2020121745A1Compositions and methods for cancer therapy with dengue virus and dendritic cellsPRIMEVAX IMMUNO ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 1845US2002172688A1HLA-restricted cytotoxic T-Lymphocytevaccine for prevention of HIV infectionFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bruce W. Lyday files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →